Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gilbert

Showing results (901-910 of 1,139) with videos related to

Pageof 114
Sort By:
European Journal of Immunology|February 13, 2008
Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium bergheiArturo Reyes-Sandoval, Saranya Sridhar, Tamara Berthoud, et al.
Vaccine|February 21, 2006
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersD P Webster, S Dunachie, S McConkey, et al.
Circulation|November 21, 2007
First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteersJames C Gilbert, Tia DeFeo-Fraulini, Renta M Hutabarat, et al.
Oncotarget|July 20, 2019
Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma <i>in vivo</i>Elgilda Musi, Gary K Schwartz, Jae Hyuk Yoo, et al.
Plos One|August 21, 2014
4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaquesAlexandra J Spencer, Julie Furze, Jared D Honeycutt, et al.
Journal of Pediatric Surgery|July 11, 1998
Cervical ECMO cannula placement in infants and children: recommendations for assessment of adequate positioning and functionM S Irish, S J O'Toole, P Kapur, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virusRichard J Anderson, Carolyn M Hannan, Sarah C Gilbert, et al.
Human Vaccines|January 12, 2010
Prime-boost vectored malaria vaccines: progress and prospectsAdrian V S Hill, Arturo Reyes-Sandoval, Geraldine O'Hara, et al.
International Journal of Cancer|September 24, 2004
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceCaroline L Smith, P Rod Dunbar, Fareed Mirza, et al.
Vaccine|April 23, 2003
Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersV S Moorthy, S McConkey, M Roberts, et al.
Pageof 114

Showing results (901-910 of 1,139) with videos related to

Sort By:
Pageof 114
European Journal of Immunology|February 13, 2008
Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium bergheiArturo Reyes-Sandoval, Saranya Sridhar, Tamara Berthoud, et al.
Vaccine|February 21, 2006
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersD P Webster, S Dunachie, S McConkey, et al.
Circulation|November 21, 2007
First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteersJames C Gilbert, Tia DeFeo-Fraulini, Renta M Hutabarat, et al.
Oncotarget|July 20, 2019
Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma <i>in vivo</i>Elgilda Musi, Gary K Schwartz, Jae Hyuk Yoo, et al.
Plos One|August 21, 2014
4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaquesAlexandra J Spencer, Julie Furze, Jared D Honeycutt, et al.
Journal of Pediatric Surgery|July 11, 1998
Cervical ECMO cannula placement in infants and children: recommendations for assessment of adequate positioning and functionM S Irish, S J O'Toole, P Kapur, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virusRichard J Anderson, Carolyn M Hannan, Sarah C Gilbert, et al.
Human Vaccines|January 12, 2010
Prime-boost vectored malaria vaccines: progress and prospectsAdrian V S Hill, Arturo Reyes-Sandoval, Geraldine O'Hara, et al.
International Journal of Cancer|September 24, 2004
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceCaroline L Smith, P Rod Dunbar, Fareed Mirza, et al.
Vaccine|April 23, 2003
Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersV S Moorthy, S McConkey, M Roberts, et al.
Pageof 114